U.S. Health Secretary Robert F. Kennedy Jr. reignited vaccine controversy this week by repeating debunked claims about the MMR (Measles, Mumps, Rubella) vaccine during a growing measles outbreak, one of the worst in 25 years. Kennedy alleged that the vaccine contains cells from aborted fetuses and questioned the efficacy of the mumps component, sparking backlash from medical experts.
The outbreak, centered in a Mennonite community in Texas, has spread to Oklahoma, Kansas, and New Mexico, infecting hundreds and killing two children. Scientists warn the U.S. may lose its measles elimination status, achieved in 2000, if vaccination rates continue to decline.
Kennedy, long known for promoting vaccine skepticism, claimed in a News Nation interview that religious groups avoid the MMR vaccine due to "aborted fetus debris." However, experts clarified that while the rubella component is produced using a fetal cell line from a 1960s abortion, no actual fetal cells are present in the final vaccine. These lab-grown cells have been replicated for decades and are filtered out during production, leaving only a purified, weakened virus.
According to Dr. Miriam Laufer from the University of Maryland and Dr. Paulo Verardi from the University of Connecticut, any DNA remnants in the final vaccine are negligible—measured in billionths of a gram.
Kennedy also said the mumps portion of the vaccine “doesn’t work” and lacked proper safety testing. However, the CDC reports that two doses of MMR provide about 86% protection against mumps. While immunity may wane over time, vaccinated individuals typically experience milder symptoms if infected.
The Department of Health and Human Services declined to comment on Kennedy’s statements, which many experts say undermine public trust in proven vaccine science.


Major Drugmakers Slash U.S. Prices and Sell Directly to Patients Amid Trump’s Push for Affordable Medicines
Senators Warn Trump Against Unauthorized Venezuela Strike, Vow War Powers Push
UN Chief Says Gaza Operation “Fundamentally Wrong” as Concerns Over War Crimes Grow
New Orleans Immigration Crackdown Sparks Fear as Federal Arrests Intensify
CDC Shake-Up Sparks Vaccine Policy Clash Between RFK Jr. and Susan Monarez
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates
Pfizer Sues Novo Nordisk Over Alleged Tactics to Block Obesity Drug Competition
Bayer’s Stroke Drug Achieves Breakthrough Trial Results, Boosting Market Confidence
FDA Memo Raises Questions About Possible COVID-19 Vaccine Links to Rare Child Deaths
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio
Australia Progresses AUKUS Review as U.S. Affirms Strong Support
Trump’s Name Appears on U.S. Institute of Peace Ahead of Rwanda–Congo Deal Signing
Michael Dell Pledges $6.25 Billion to Boost Children’s Investment Accounts Under Trump Initiative
Drones Spotted Near Zelenskiy’s Flight Path in Ireland Trigger Security Alert
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment 



